This inventor holds 274 USPTO granted patents and 33 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Memristor Technology (CPC class H01L45-146). Top assignees: Hewlett-Packard Development Company, L.p., Hewlett Packard Enterprise Development LP, Endovascular Technologies, Inc.. Active years: 1977-2022.
Inventors with similar research interests:
Location History:
- Benton Harbor, MI (US) (1977 - 1986)
- Bussem, NL (2001)
- Mt View, CA (US) (2004 - 2005)
- Mountain View, CA (US) (1999 - 2006)
- Sunnyvale, CA (US) (1997 - 2007)
- Portola, CA (US) (2009)
- Redwood, CA (US) (2005 - 2010)
- Redwwod City, CA (US) (2010)
- Portolla Valley, CA (US) (2012)
- Portols Valley, CA (US) (2013)
- Palo Alto, CA (US) (2008 - 2019)
- Redwood City, CA (US) (2002 - 2022)
- Portola Valley, CA (US) (2006 - 2022)
Company Filing History:
196 out of 27,667 
27 out of 5,644 
13 out of 151 
Years Active: 1977-2022
Areas of Expertise:
Title: Richard Stanley Williams: Innovating in Cryogenic Ablation Systems
Introduction:
Richard Stanley Williams is a prolific inventor based in Redwood City, CA, with an impressive portfolio of 39 patents. His groundbreaking work in the field of cryogenic ablation systems has revolutionized the treatment of esophageal target tissue. Let's delve into his latest patents, career highlights, collaborations, and the impact of his inventions.
Latest Patents:
Among Richard Stanley Williams' recent patents is the cryogenic ablation system and method, a medical device designed to treat esophageal target tissue. This device includes a catheter, a balloon, and a refrigerant delivery device. By delivering refrigerant into the balloon, it can be expanded and cooled, allowing it to effectively press against and cool the esophageal target tissue. The invention also incorporates mechanisms for sensing balloon leaks, ensuring the device's safety and effectiveness.
Career Highlights:
Richard Stanley Williams has had an impactful career in the medical technology industry, primarily with companies such as Endovascular Technologies and Cryovascular Systems. His contributions have significantly advanced the field of cryogenic ablation systems, making a difference in patient care and outcomes. Through his inventions, he has demonstrated a deep understanding of the challenges in treating esophageal target tissue and has developed innovative solutions.
Collaborations:
Throughout his career, Richard Stanley Williams has collaborated with several notable individuals, including Ronald G. Williams and James D. Joye. These collaborations are indicative of his ability to work effectively in interdisciplinary teams, combining expertise to drive innovation and achieve successful outcomes. The collective efforts of these collaborations have resulted in significant advancements in cryogenic ablation systems.
Conclusion:
Richard Stanley Williams' impact in the field of cryogenic ablation systems is undeniable. With 39 patents to his name, he has demonstrated a remarkable ability to develop innovative solutions for treating esophageal target tissue. His inventions, such as the cryogenic ablation system and method, have the potential to enhance patient care and improve treatment outcomes. Richard Stanley Williams' continued contributions and collaborations exemplify his commitment to innovation and advancing medical technology.